The tariff classification of Pyrilamine Maleate (CAS No. 59-33-6) in bulk form, from India
Issued February 5, 2021 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2933.39.4100
Headings: 2933
Product description
Pyrilamine Maleate is an antihistamine used to treat the common cold and menstrual cramps. Pyrilamine is also known as Mepyramine (INN).
CBP rationale
The applicable subheading for the Pyrilamine Maleate in bulk form will be 2933.39.4100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.
Full text
N316934 February 5, 2021 CLA-2-29:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 2933.39.4100 Ms. Dagmara A. Charyk CellMark USA, LLC 2 Corporate Drive, Shelton, CT 06484 RE: The tariff classification of Pyrilamine Maleate (CAS No. 59-33-6) in bulk form, from India Dear Ms. Charyk: In your letter dated January 13, 2021, you requested a tariff classification ruling. Pyrilamine Maleate is an antihistamine used to treat the common cold and menstrual cramps. Pyrilamine is also known as Mepyramine (INN). The applicable subheading for the Pyrilamine Maleate in bulk form will be 2933.39.4100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Roflumilast (CAS No. 162401-32-3), imported in bulk form, from Mexico
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia
The tariff classification of Revefenacin (CAS No. 864750-70-9) in bulk form, from France
The tariff classification of Maropitant Citrate Monohydrate (CAS No. 359875-09-5) in bulk power form, from Italy
The tariff classification of Maropitant (CAS No. 147116-67-4) in bulk powder form, from Italy
The tariff classification of Difelikefalin Acetate (CAS No. 1024829-44-4) in bulk form, from Taiwan
The tariff classification of Tolperisone Hydrochloride (CAS No. 3644-61-9) in bulk form, from Mexico and Austria
The tariff classification of Brompheniramine Maleate (CAS No. 980-71-2) in bulk form, from India
The tariff classification of Ropivacaine Hydrochloride Monohydrate (CAS No. 132112-35-7) in bulk powder form, from Belgium
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →